The next big advance in cancer treatment could be a vaccine that can shrink tumours and stop cancer from returning, US experts have said.
More than ever, scientists understand how cancer hides from the body’s immune system. Cancer vaccines, like other immunotherapies, boost the immune system to find and kill cancer cells. Some new ones use mRNA, which was developed for cancer but was first used for Covid-19 vaccines.
People with the inherited condition known as Lynch syndrome have a 60 per cent to 80 per cent lifetime risk of developing cancer. Recruiting them for cancer vaccine trials has been remarkably easy, said Dr Eduardo Vilar-Sanchez of MD Anderson Cancer Centre in Houston, who is leading two government-funded studies on vaccines for Lynch-related cancers.
Lynch Syndrome Ireland 